A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT07687914 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07687914
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-23
- Primary completion
- 2027-07-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.